Ultra Adsorb, capsules 200 mg, 30 pcs.

Adsorbent agent.

High surface activity and high sorption capacity.

Limits absorption of toxic substances, salts of heavy metals, alkaloids and glycosides, medicinal substances from the gastrointestinal tract, helping their elimination from the body.

Absorbs gases on its surface.

Indications

As an enterosorbing agent for detoxification during exogenous and endogenous intoxications:

flatulence,
dyspepsia,
processes of rotting, fermentation, hypersecretion of mucus and gastric juice:
diarrhea,
acute intestinal infections,
poisoning with chemical compounds and drugs (including organophosphorus and organochlorine compounds, psychoactive drugs),
poisoning with alkaloids, glycosides, salts of heavy metals,
food intoxication; food poisoning, dysentery, salmonellosis,
alcohol withdrawal syndrome.

As an enterosorbent agent in complex therapy, the drug is indicated for:

burn disease in the stage of toxemia and septicotoxemia;
renal failure,
chronic hepatitis, acute viral hepatitis, liver cirrhosis,
atopic dermatitis,
bronchial asthma,
gastritis, chronic cholecystitis, enterocolitis, cholecystopancreatitis;
treatment of allergic diseases,
treatment of metabolic disorders,
treatment of intoxication in cancer patients during radiation and chemotherapy;
preparation for x-ray and endoscopic examinations (to reduce the content of gases in the intestines).

Pharmacological effect

Adsorbent.

It has high surface activity and high sorption capacity.

Reduces the absorption of toxic substances, heavy metal salts, alkaloids and glycosides, and medicinal substances from the gastrointestinal tract, facilitating their removal from the body.

Adsorbs gases on its surface.

Special instructions

When treating intoxications, it is necessary to create an excess of carbon in the stomach (before gastric lavage) and in the intestines (after gastric lavage). Reducing the concentration of carbon in the medium promotes desorption of the bound substance and its absorption (to prevent resorption of the released substance, repeated gastric lavage and administration of carbon are recommended).

The presence of food masses in the gastrointestinal tract requires the introduction of activated carbon in high doses, because the contents of the gastrointestinal tract are sorbed by carbon and its activity decreases.

If poisoning is caused by substances involved in enterohepatic circulation (cardiac glycosides, indomethacin, morphine and other opiates), it is necessary to use charcoal for several days. When using the drug for more than 10-14 days, prophylactic administration of vitamins and calcium supplements is necessary (only under the supervision of a doctor).

Ultra-Adsorb should be stored separately from substances that release gases or vapors into the atmosphere. Storage in air (especially humid) reduces the sorption capacity of coal.

The use of Ultra-Adsorb can lead to black stool, which is not a clinical symptom.

Active ingredient

Activated carbon

Composition

1 capsule contains:

active ingredient:

200 mg activated carbon,

excipients:

gelatin -73, 18 mg,

titanium dioxide (E171) – 0.15 mg,

iron oxide black (E172) – 1.67 mg.

Pregnancy

During pregnancy and lactation, be sure to consult a doctor before taking Ultra-Adsorb.

Contraindicated for children under 3 years of age.

Contraindications

hypersensitivity,
ulcerative lesions of the gastrointestinal tract (including peptic ulcer of the stomach and duodenum, nonspecific ulcerative colitis),
gastrointestinal bleeding,
simultaneous administration of antitoxic drugs, the effect of which develops after absorption (methionine, etc.).

Side Effects

Dyspepsia, constipation or diarrhea; with long-term use – hypovitaminosis, decreased absorption of nutrients (fats, proteins), hormones from the gastrointestinal tract.

With hemoperfusion through activated carbon – thromboembolism, hemorrhages, hypoglycemia, hypocalcemia, hypothermia, decreased blood pressure.

Interaction

Reduces the effectiveness of concomitantly taken medications, incl. antitoxic drugs, the effect of which develops after absorption (methionine, etc.).

Reduces the effectiveness of drugs acting on the mucous membrane of the gastrointestinal tract (including ipecac and thermopsis).

Storage conditions

In a dry place, at a temperature not exceeding 25 °C

Shelf life

5 years

Manufacturer

Lainco, Spain